Real World Experience with the T2Candida Panel.
Sandy Estrada, Pharm. D., Infectious Diseases Clinical Pharmacist
WEBINAR: The Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship
Save Lives and Money
Reduce 60% of Candida deaths and save $30K per patient.
How to detect Candida pathogens commonly associated with sepsis - independent of blood culture.
T2Candida demonstrates 91.1% sensitivity and 99.4% specificity. Learn more.
News & Events
November 3, 2016
ata Demonstrates Clinical and Economic Benefits of T2 Magnetic Resonance (T2MR®) Technology in Clinical Settings
September 28, 2016
T2Candida Panel nominated for the "Discovery of the Decade" award by the Prix Galien Foundation.
July 28, 2016
Advance for the Laboratory interviews T2's Tom Lowery, PhD Emerging Methodology: A game-changer in the always-urgent detection of sepsis.